Status:
COMPLETED
Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care
Lead Sponsor:
Nationwide Children's Hospital
Conditions:
Cellulitis
Abscess
Eligibility:
All Genders
3-99 years
Phase:
NA
Brief Summary
Study the efficacy of a package of behavioral economics strategies (versus an education-only control condition) in altering clinician behavior regarding antibiotic prescription duration for skin and s...
Detailed Description
The investigators propose a prospective, cluster randomized trial of Epic order panels in the 14 Nationwide Children's Hospital (NCH) primary care clinics. Investigators have designed user-friendly Ep...
Eligibility Criteria
Inclusion
- diagnosis codes A46 (cellulitis), L03 (cellulitis and acute lymphangitis), J34 or L02 (abscess, furuncle), or L01 (impetigo) AND
- those who received a prescription for an enteral antibiotic
- patient's treated in Nationwide Children's Hospital primary care clinics
Exclusion
- Patients less than 3 months of age
- Animal bite
- Human bite
- Foreign body
- Diagnosis of hidradenitis suppurativa
- Immunocompromising conditions (primary immune deficiency, chemotherapy, etc)
- burns
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2025
Estimated Enrollment :
1634 Patients enrolled
Trial Details
Trial ID
NCT05226260
Start Date
November 1 2021
End Date
January 20 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital Primary Care Clinics
Columbus, Ohio, United States, 43205